| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sharir Keren | President | 26 REWEZ ST., TEL AVIV, ISRAEL | Keren Sharir by: Oppenheimer Israel, as Attorney-in-fact | 16 Mar 2026 | 0002081580 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NYAX | Ordinary Shares | 3,525 | 16 Mar 2026 | Direct | F1 | |||||
| holding | NYAX | Ordinary Shares | 3,000 | 16 Mar 2026 | Direct | F2 | |||||
| holding | NYAX | Ordinary Shares | 2,074 | 16 Mar 2026 | Direct | F3 | |||||
| holding | NYAX | Ordinary Shares | 1,277 | 16 Mar 2026 | Direct | F4 | |||||
| holding | NYAX | Ordinary Shares | 5,000 | 16 Mar 2026 | Direct | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NYAX | Stock Option (Right to Buy) | 16 Mar 2026 | Ordinary Shares | 27,600 | $6.70 | Direct | F6 | ||||||
| holding | NYAX | Stock Option (Right to Buy) | 16 Mar 2026 | Ordinary Shares | 10,000 | $38.74 | Direct | F7, F8 |
| Id | Content |
|---|---|
| F1 | The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Nayax Ltd. (the "Company"). The RSUs vest 25% on the first year (06/26/2024 ) and the remaining 75% vest in twelve equal quarterly installments over a three-year period, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. |
| F2 | The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Nayax Ltd. (the "Company"). The RSUs vest 25% on the first year (06/25/2025 ) and the remaining 75% vest in twelve equal quarterly installments over a three-year period, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. |
| F3 | The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Nayax Ltd. (the "Company"). The RSUs vest 25% on the first year (06/03/2026 ) and the remaining 75% vest in twelve equal quarterly installments over a three-year period, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. |
| F4 | The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Nayax Ltd. (the "Company"). Update Manually |
| F5 | The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Nayax Ltd. (the "Company"). The RSUs vest 25% on the first year (03/28/2023 ) and the remaining 75% vest in twelve equal quarterly installments over a three-year period, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. |
| F6 | The Stock Options are Fully vested and immediately exercisable |
| F7 | The Options vest 20% on the first year (11/17/2022 ) and the remaining 80% vest in sixteen equal quarterly installments over a four-year period, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. |
| F8 | The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date. |
This Form 3 is being filed to report the Reporting Persons beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.